Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/13/23 16:02 | 12/11/23 | ATXI | Health | Drug | Pharmaceutical Preparations | Davidow Robert L | FL | T | S | -87 | 0.1403 | 0 | -617 | -34 | 1,220 | M | |||||||||||||||
10/13/22 20:52 | 10/11/22 | ATXI | Health | Drug | Pharmaceutical Preparations | Invagen Pharmaceuticals, Inc. | NY | T | S | -3,000 | 7.71 | 0 | -389 | -100 | 0 | D | |||||||||||||||
9/15/21 16:03 | 9/15/21 | ATXI | Health | Drug | Pharmaceutical Preparations | Vazzano Joseph Walter | NY | O | CFO | S | -12 | 1.62 | 0 | -7 | -10 | 65 | D | ||||||||||||||
8/21/20 16:15 | 8/20/20 | ATXI | Health | Drug | Pharmaceutical Preparations | Vazzano Joseph Walter | NY | O | CFO | S | -47 | 12.13 | 0 | -4 | -6 | 57 | D | ||||||||||||||
8/12/19 16:19 | 8/8/19 | ATXI | Health | Drug | Pharmaceutical Preparations | Vazzano Joseph Walter | NY | O | CFO | S.m | -26 | 5.59 | 0 | -5 | -8 | 57 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |